These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 33728186)
1. T-Cell Prolymphocytic Leukemia: An Overview of Current and Future Approaches. Colon Ramos A; Tarekegn K; Aujla A; Garcia de de Jesus K; Gupta S Cureus; 2021 Feb; 13(2):e13237. PubMed ID: 33728186 [TBL] [Abstract][Full Text] [Related]
2. Advances and Perspectives in the Treatment of T-PLL. Braun T; von Jan J; Wahnschaffe L; Herling M Curr Hematol Malig Rep; 2020 Apr; 15(2):113-124. PubMed ID: 32034661 [TBL] [Abstract][Full Text] [Related]
3. T-Cell Prolymphocytic Leukemia: Diagnosis, Pathogenesis, and Treatment. Gutierrez M; Bladek P; Goksu B; Murga-Zamalloa C; Bixby D; Wilcox R Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569479 [TBL] [Abstract][Full Text] [Related]
4. Current understandings on T-cell prolymphocytic leukemia and its association with TCL1 proto-oncogene. Sun S; Fang W Biomed Pharmacother; 2020 Jun; 126():110107. PubMed ID: 32247279 [TBL] [Abstract][Full Text] [Related]
5. T-Cell Prolymphocytic Leukemia With t(X;14)(q28;q11.2): A Clinicopathologic Study of 15 Cases. Hu Z; Medeiros LJ; Xu M; Yuan J; Peker D; Shao L; Tang Z; Mai B; Thakral B; Rios A; Hu S; Wang W Am J Clin Pathol; 2023 Apr; 159(4):325-336. PubMed ID: 36883805 [TBL] [Abstract][Full Text] [Related]
6. Prolymphocytic Leukemia: New Insights in Diagnosis and in Treatment. Collignon A; Wanquet A; Maitre E; Cornet E; Troussard X; Aurran-Schleinitz T Curr Oncol Rep; 2017 Apr; 19(4):29. PubMed ID: 28324286 [TBL] [Abstract][Full Text] [Related]
7. B and T cell prolymphocytic leukaemia. Cross M; Dearden C Best Pract Res Clin Haematol; 2019 Sep; 32(3):217-228. PubMed ID: 31585622 [TBL] [Abstract][Full Text] [Related]
8. Partial response to venetoclax and ruxolitinib combination in a case of refractory T-prolymphocytic leukemia. Brothers J; Castillo DR; Jeon WJ; Joung B; Linhares Y Hematology; 2023 Dec; 28(1):2237342. PubMed ID: 37485976 [No Abstract] [Full Text] [Related]
9. Prognostic significance of cytogenetic abnormalities in T-cell prolymphocytic leukemia. Hu Z; Medeiros LJ; Fang L; Sun Y; Tang Z; Tang G; Sun T; Quesada AE; Hu S; Wang SA; Pei L; Lu X Am J Hematol; 2017 May; 92(5):441-447. PubMed ID: 28194886 [TBL] [Abstract][Full Text] [Related]
10. Advances in the understanding and management of T-cell prolymphocytic leukemia. Laribi K; Lemaire P; Sandrini J; Baugier de Materre A Oncotarget; 2017 Nov; 8(61):104664-104686. PubMed ID: 29262669 [TBL] [Abstract][Full Text] [Related]
11. Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling. Andersson EI; Pützer S; Yadav B; Dufva O; Khan S; He L; Sellner L; Schrader A; Crispatzu G; Oleś M; Zhang H; Adnan-Awad S; Lagström S; Bellanger D; Mpindi JP; Eldfors S; Pemovska T; Pietarinen P; Lauhio A; Tomska K; Cuesta-Mateos C; Faber E; Koschmieder S; Brümmendorf TH; Kytölä S; Savolainen ER; Siitonen T; Ellonen P; Kallioniemi O; Wennerberg K; Ding W; Stern MH; Huber W; Anders S; Tang J; Aittokallio T; Zenz T; Herling M; Mustjoki S Leukemia; 2018 Mar; 32(3):774-787. PubMed ID: 28804127 [TBL] [Abstract][Full Text] [Related]
12. A patient with white blood cell counts more than a million: A diagnostic and therapeutic challenge. Figueroa-Jiménez LA; Cabrera-Márquez AL; Báez-Díaz L; Cáceres-Perkins W Bisturi (S Juan); 2016; 2016():12-16. PubMed ID: 29238632 [TBL] [Abstract][Full Text] [Related]
13. Delineation of clinical course, outcomes, and prognostic factors in patients with T-cell prolymphocytic leukemia. Rose A; Zhang L; Jain AG; Poovathukaran Babu A; Sokol L; Saeed H; Mo Q; Fan W; Zhang X Am J Hematol; 2023 Jun; 98(6):913-921. PubMed ID: 36964941 [TBL] [Abstract][Full Text] [Related]
14. A case report of T cell prolymphocytic leukemia and Kaposi sarcoma and a review of T cell prolymphocytic leukemia. Paul RN; Alizadeh L; Ajayi OI; Karpurapu H; Ganesan C; Taddesse-Heath L; Aggarwal A Acta Haematol; 2012; 127(4):235-43. PubMed ID: 22517037 [TBL] [Abstract][Full Text] [Related]
15. [Transgenic mice expressing MTCP1: an animal model for T-cell prolymphocytic leukemia]. Chiali-Gritti C Ann Pharm Fr; 2000 Jan; 58(1):54-61. PubMed ID: 10669814 [TBL] [Abstract][Full Text] [Related]
16. Does a subset of mature T-cell leukemias with features akin to T-cell prolymphocytic leukemia but lacking rearrangement of the Gajzer DC; Chen X; Sabath DE; Poh C; Naresh KN EJHaem; 2024 Aug; 5(4):900-904. PubMed ID: 39157608 [TBL] [Abstract][Full Text] [Related]